SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
TRAX

First Tracks Biotherapeutics, Inc. (NASDAQ:TRAX)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$41.64-$2.82 (-6.34%)
 
Market cap
$1.75B
Insider Score
Health Score
Analyst consensus
Listed since
Apr 20, 2026
Market Cap$1.75B+119.2%
Revenue (ttm)$0
Net Income-$115.21M
EPS-$3.27
Shares Out42.02M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume504,364
Open$43.99
Previous Close$44.46
Day's Range$41.52 - $44.51
52-Week Range$14.72 - $54.78
Beta3.37
AnalystsBuy
Price Target$72.44(+73.97%)
Earnings DateFeb 2, 2027

About TRAX

First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.

Address
10770 Wateridge Circle, San Diego, CA, 92121, US
Market Cap
1.75 billion
Employees
104
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$66.74M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

When insiders bought and sold

1 year · open-market trades only
Closing Price Purchase Sale
$14.09$34.52$54.95MayJulSepNov

Analyst consensus

Moderate Buy
6 Buy0 Hold0 SellAvg target $61.50 (+47.7%)

6 firms rating TRAX in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Sound
From TRAX’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-6.34%
5 Days
-10.49%
1 Month
-3.48%
6 Months
+142.37%
1 Year
+119.16%

$TRAX stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in TRAX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by TRAX's directors and management

Net Shares Purchased by Insiders−5M−2.5M02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

TRAX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New TRAX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to TRAX from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in TRAX

VTIVanguard Morningstar Total Stock Market ETF$40.72M
XBIState Street SPDR S&P Biotech ETF$39.84M
IWMiShares Russell 2000 ETF$38.97M
VXFVanguard Extended Market ETF$15.59M
IWOiShares Russell 2000 Growth ETF$9.76M
VTWOVanguard Russell 2000 ETF$8.88M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from TRAX’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
0
Analyst Ratings
40% of score
99
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
2
Buy Value
$0
Distinct Buyers
0

Insider Score Trend Over Time

+0.0 since Sep 5
0255075100Sep 5 — Insider Score 0.0Sep 6 — Insider Score 0.0Sep 7 — Insider Score 0.0Sep 8 — Insider Score 0.0Sep 9 — Insider Score 0.0Sep 10 — Insider Score 0.0Sep 11 — Insider Score 0.0Sep 12 — Insider Score 0.0Sep 13 — Insider Score 0.0Sep 14 — Insider Score 0.0Sep 15 — Insider Score 0.0Sep 16 — Insider Score 0.0Sep 17 — Insider Score 0.0Sep 18 — Insider Score 0.0Sep 19 — Insider Score 0.0Sep 20 — Insider Score 0.0Sep 21 — Insider Score 0.0Sep 22 — Insider Score 0.0Sep 23 — Insider Score 0.0Sep 24 — Insider Score 0.0Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 27.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Sep 5Sep 19Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

BBCVirtus Biotech Clinical Trials ETF2.12%
TDNAT. Rowe Price Biotech ETF0.79%
HELXFranklin Genomic Advancements ETF0.75%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.68%
SGRWHarbor Active Small Cap Growth ETF (SGRW)0.66%
XBIState Street SPDR S&P Biotech ETF0.43%
IWCiShares Micro-Cap ETF0.42%
PJSMPGIM Jennison Small-Mid Cap Core Equity ETF0.17%
IBBQInvesco Nasdaq Biotechnology ETF0.11%
ESLGEventide Large Cap Growth ETF0.09%
FSEGFidelity Enhanced Small Cap Growth ETF0.09%
PWSPacer WealthShield ETF0.09%

Weight is the stock’s share of each fund’s holdings.